Month: September 2026

Summit to be hosted at site of Genius City in Nuanu, Bali, Indonesia, with speakers including Futurists Dr Michio Kaku and Peter Diamandis.

SINGAPORE, Sept. 22, 2026 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group”, “GNS” or the “Company”), a leading AI-powered education group, today announced details for the second year of the Genius Future Summit, taking place on November 5-6, 2026.

Billed as Asia’s No.1 Event for Entrepreneur, Changemakers and Visioneers, the Summit will take place at the site of Genius City in Nuanu, Bali.

The Annual Genius Future Summit brings together the world’s brightest leaders, innovators, and thinkers to explore the top trends shaping our future. Over two immersive days, attendees gain insights, connections, and strategies to thrive in the decade ahead.

This year’s headline speakers include:

Dr Michio Kaku: Theoretical physicist, bestselling author, acclaimed public speaker, futurist, and popularizer of science, he co-founded “String Field Theory” and continues Einstein’s quest to unite the fundamental forces of nature into a single grand unified “Theory of Everything.”

Dr. Kaku held the Henry Semat Chair in Theoretical Physics at City University New York, graduating summa cum laude from Harvard with a Ph.D. from UC Berkeley, and is a recipient of the Arthur C. Clarke Lifetime Achievement Award. He has written numerous New York Times bestselling books including The Future of Humanity, The Future of the Mind, Physics of the Future, Physics of the Impossible and The God Equation: The Quest for a Theory of Everything.

Peter Diamandis: A pioneer in innovation, longevity, and exponential technologies, and named by Fortune as one of the World’s 50 Greatest Leaders.

Mr. Diamandis is the Founder and Executive Chairman of XPRIZE Foundation, which has launched over $600 million in competitions, driving more than $10 billion in research and development across space, health, robotics, climate, quantum, and AI. He also co-founded Singularity University, Link-Exponential Ventures, BOLD Capital Partners, and multiple companies focused on extending human healthspan and accelerating technological progress.

Summit speakers also include:

• Roger James Hamilton, Founder & CEO of Genius Group Ltd
• Lev Kroll, CEO of Nuanu Creative City
• Merry Riana, Entrepreneur and Founder of Merry Riana Learning Centre
• Iwan Sugata, Founder and Catalyst, MANOUV
• Eva Mantziou, Chief People Officer & Chief Legal Officer of Genius Group
• Charlie Hearn, Founder of Inspiral Architecture and Design Studios
• Jacek Kaczynski, Education Innovator, Discover Lab Indonesia
• Ni Komang Sri Junisabtika, Venue Manager of Magic Garden

Highlights of the summit include:

• The top 10 trends in the ABC’s of the Future: AI, Blockchain, and Community
• Forums on Entrepreneurship, Education and Environment
• Launch of the inaugural Genius Awards, highlighting AI powered, impact driven projects.
• Tour of the rapidly growing Genius School campus and Future School model
• Launch of the Genius City showcase and launch roadmap.

Genius Group’s CEO, Roger James Hamilton, said “Following the success of the first Genius Future Summit in 2025, we are looking forward to welcoming back entrepreneurs, investors and changemakers from across Asia for our second annual summit. The accelerating rate of change across all exponential technologies makes the topic of our summit more relevant than ever this year. We also look forward to welcoming students of Genius School as well as our first cohort of humanoid robots, who will be joining our attendees for the first time this November.”

To find out more about the Genius Future Summit, visit:
https://geniusbali.ai/genius-future-summit-2026

About Genius Group

Genius Group (NYSE: GNS) is a global education group delivering AI powered, education and acceleration solutions for the future of work. Genius Group serves 6 million users in over 100 countries through its Genius City model and online digital marketplace of AI training, AI tools and AI talent. It provides personalized, entrepreneurial AI pathways combining human talent with AI skills and AI solutions at the individual, enterprise and government level. To learn more, please visit geniusgroup.ai

Forward-Looking Statements 

Statements made in this press release include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements can be identified by the use of words such as “may,” “will”, “plan,” “should,” “expect,” “anticipate,” “estimate,” “continue,” or comparable terminology. Such forward-looking statements are inherently subject to certain risks, trends and uncertainties, many of which the Company cannot predict with accuracy and some of which the Company might not even anticipate and involve factors that may cause actual results to differ materially from those projected or suggested. Readers are cautioned not to place undue reliance on these forward-looking statements and are advised to consider the factors listed above together with the additional factors under the heading “Risk Factors” in the Company’s Annual Reports on Form 20-F, as may be supplemented or amended by the Company’s Reports of a Foreign Private Issuer on Form 6-K. The Company assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events, new information or otherwise. No information in this press release should be construed as any indication whatsoever of the Company’s future revenues, results of operations, or stock price.

Contacts
For enquiries, contact investor@geniusgroup.ai

• SemiCab Initiatives Focused on Near-Term Break-Even Operations and Strategic Partnerships
• Newly Acquired Azure Energy Has More Than $10 Million in Active Contracted Revenue Through 2027
• Management Focused on Expanding Revenue and EBITDA Through Azure Existing Customers and Strategic Partnerships
• Company Targets Lower Cost of Capital and Reduced Reliance on Dilutive Financing

FORT LAUDERDALE, FL., Sept. 22, 2026 (GLOBE NEWSWIRE) — Algorhythm Holdings, Inc. (the “Company”) (NASDAQ: RIME), a diversified holding company and owner of SemiCab, an AI-enabled logistics technology business, and Azure Energy, a renewable power infrastructure developer, today outlined its near-term operational, strategic and capital allocation priorities for the remainder of 2026 and 2027.

The update coincides with the Company’s filing of a new corporate presentation with the Securities and Exchange Commission pursuant to Regulation FD.

Driving Profitable Growth Across the Portfolio

Management’s immediate priority is to build a stronger base of recurring and profitable revenue across Algorhythm’s operating business segments.

At SemiCab, management’s immediate priority is to substantially reduce operating losses through a reduction in G&A spending, particularly at the Company’s SemiCab India division, and prioritizing SemiCab’s SaaS model which provides an opportunity to pursue a more capital-efficient business model.

The Company has taken steps to reduce SemiCab’s operating cost structure and intends to focus its investment on activities with the clearest path to near-term, high-margin returns. For longer-term opportunities, management intends to explore strategic partnerships and other capital-efficient structures designed to monetize SemiCab’s technology while limiting additional investment requirements.

At Azure Energy, the Company currently has three customers providing significant revenue visibility under existing contracts, representing more than $10 million of contracted high-margin fee revenue through the end of 2027. The Company is also negotiating additional opportunities that, if successfully contracted, are expected to contribute incremental revenue during 2027. Two of these opportunities involve existing customers of Azure and its affiliates, providing the potential to expand established commercial relationships.

Expanding Through Capital-Efficient Strategic Partnerships

Strategic partnerships represent an important component of the Company’s growth strategy across both SemiCab and Azure.

At Azure, the Company intends to pursue project-specific relationships with established construction and infrastructure firms to expand its participation in large-scale power generation projects. Under this model, Azure would contribute its engineering, project development and technical expertise while its partners provide complementary construction capabilities and commercial bonding capacity.

Management currently believes these relationships could enable Azure to expand into the procurement phase of Engineering, Procurement and Construction (“EPC”) engagements without independently assuming the full capital and bonding requirements associated with those projects. One such opportunity could expand Azure’s existing relationship with a Fortune 500 food and beverage company.

Strengthening Algorhythm’s Balance Sheet and Capital Structure

Management’s third priority is to strengthen Algorhythm’s balance sheet, reduce its cost of capital and decrease reliance on potentially dilutive financing.

As the Company seeks to expand its base of contracted revenue and operating cash flow, management intends to evaluate opportunities to selectively use cash on hand and future cash flows to repay, restructure or refinance higher-cost financing instruments currently outstanding.

Management also intends to pursue lower-cost financing alternatives that may become available as the Company’s revenue base and operating cash flow grow. The objective is to reduce reliance on equity-linked financing while preserving sufficient liquidity to support attractive growth opportunities across the Company’s businesses.

Focused on Execution

“Our priorities for Algorhythm are clear,” said Andrew Thompson, Chief Executive Officer of Algorhythm Holdings. “First, we are focused on driving sustained, profitable revenue growth. Azure brings to the Company more than $10 million of existing contracted revenue, established customer relationships and a growing pipeline of opportunities in power generation infrastructure. Our immediate objective is to execute against that foundation and expand it.”

“Second, we are taking a disciplined approach to how we deploy capital across the Company. With SemiCab, our priority is to substantially reduce operating losses while pursuing partnership structures that can preserve the value of its technology and customer relationships. With Azure, believe strategic partnerships can allow us to participate in larger power generation projects without independently assuming all of the customary capital and bonding requirements.”

“Finally, we are focused on strengthening Algorhythm’s capital structure,” Thompson concluded. “As we grow revenue and operating cash flow, we intend to pursue opportunities to reduce higher-cost financing and our reliance on dilutive sources of capital. Our objective is straightforward: grow profitable revenue, allocate capital where we see the strongest returns, and build a stronger financial foundation for Algorhythm and its shareholders.”

About Algorhythm Holdings

Algorhythm Holdings, Inc. is a holding Company, with two primary assets, SemiCab and Azure Energy.

SemiCab is an AI-enabled logistics software provider. Since 2020, SemiCab has enabled major retailers, brands and transportation providers to address common supply-chain problems globally. Its AI-enabled, cloud-based Collaborative Transportation Platform achieves the scalability required to predict and optimize millions of loads and hundreds of thousands of trucks. SemiCab uses real-time data from API-based load tendering and pre-built integrations with TMS and ELD partners to orchestrate collaboration across manufacturers, retailers, distributors, and their carriers. SemiCab uses AI/ML predictions and advanced predictive optimization models to enable fully loaded round trips. With SemiCab’s AI platform, shippers pay less and carriers make more without having to change a thing. For additional information, please go to: http://www.semicab.com.

Azure Energy is a leading developer of renewable biomass power generation infrastructure. Their team consists of some of the most experienced biomass power plant experts in the US today. Collectively this team has designed and built 72 facilities generating 17.5GW of renewable power to date. As Azure, this team launched in 2025 and has already secured equity participation valued at over $220 million in net present value through multiple power plants under construction in the US today. The Company has significant fee-income consulting revenues under multi-year contracts, and is generating scaling, positive EBITDA. For additional information, please go to: http://www.azure-energy.co.

Investor Relations Contact

Brendan Hopkins
407-645-5295
investors@algoholdings.com
www.algoholdings.com

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Any statement that is not historical in nature is a forward-looking statement and may be identified by the use of words and phrases such as “expects,” “anticipates,” “believes,” “plans,” “potential,” “seeks,” “should,” “strategy,” “targets,” “will” and similar references to future periods. Examples of forward-looking statements in this press release include, among others, statements regarding the Company’s expectations for revenue growth and contracted revenue at Azure Energy, anticipated reductions in SemiCab’s operating losses and general and administrative spending, plans to pursue strategic partnerships in power generation infrastructure, expectations regarding Azure Energy’s ability to expand into EPC engagements, management’s plans to strengthen the Company’s balance sheet and reduce its cost of capital, the Company’s strategy to reduce reliance on dilutive financing, and the anticipated benefits of the Company’s capital allocation priorities. These statements are based on management’s current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements, including the risk factors described from time to time in Algorhythm’s reports to the SEC, including, without limitation Algorhythm’s Annual Report on Form 10-K for the year ended December 31, 2025. You should not place undue reliance on any forward-looking statement, each of which applies only as of the date of this press release. Except as required by law, we undertake no obligation to update or revise publicly any of the forward-looking statements after the date of this press release to conform our statements to actual results or changed expectations, or as a result of new information, future events or otherwise.

Allen facility delivers eBee VISION ISR systems to the U.S. Army and begins shipping the new MicaSense RedEdge-MX sensor to commercial customers

ALLEN, Texas, Sept. 22, 2026 (GLOBE NEWSWIRE) — AgEagle Aerial Systems Inc. (dba, EagleNXT) (the “Company” or “EagleNXT”) (NYSE: UAVS), a leading provider of full-stack drone, counter-UAS, and specialty sensor system solutions for defense, government, and commercial applications worldwide, today announced that its U.S. headquarters and production facility in Allen, Texas is now shipping product across multiple lines, including eBee VISION Intelligence, Surveillance, and Reconnaissance (ISR) unmanned systems and the newly released MicaSense RedEdge-MX multispectral sensor.

Most recently, nine Allen-built eBee VISION UAS kits were delivered to the U.S. Army’s National Training Center (NTC) at Fort Irwin, California, fulfilling the order announced in April 2026. The delivery follows the first VISION units produced on the Allen line, which shipped to Fort Rucker, Alabama earlier this year.

The NTC is the Army’s premier maneuver training venue, preparing rotational units for high-intensity operations that now routinely include adversary unmanned systems and the requirement for friendly ISR at the tactical edge. The kits will support opposing force (OPFOR) realism, rotational-unit training, and counter-UAS instruction.

“Domestic production was a stated objective when we established our headquarters in Allen. It is now an operating reality,” said Bill Irby, Chief Executive Officer. “U.S.-built VISION systems are supporting training at the Army’s National Training Center, and the same facility is shipping our newest MicaSense sensor to commercial customers. Customers across defense and commercial markets are prioritizing American-made unmanned systems and sensors, and EagleNXT is maturing its domestic supply chain to meet that demand. We believe that positioning is a durable foundation for long-term shareholder value.”

The eBee VISION is a backpack-portable, hand-launched fixed-wing ISR drone that deploys in minutes and delivers long-range zoom, optional thermal imaging, and a high-definition video feed. The Group 1 UAS provides up to 90 minutes of flight endurance and a real-time video link range of up to 12 miles (20 km). It is NDAA-compliant, Blue UAS Cleared, and built to operate in GNSS-denied and contested environments.

EagleNXT is also now shipping the updated MicaSense RedEdge-MX multispectral sensor, released in July 2026, from a dedicated assembly and test cell at the Allen facility. The RedEdge-MX features a new metallic enclosure for durability in harsh field environments and is available through EagleNXT’s global network of authorized dealers and partners. The Allen site is EagleNXT’s North American hub for eBee VISION production, MicaSense sensor manufacturing, and ThirdEye USA counter-UAS assembly. Consolidating drone and sensor production in Texas also frees capacity on the Company’s Swiss manufacturing lines to serve international demand.

“U.S. leadership has made American drone production a defense priority,” continued Irby. “Shipping both drones and sensors from Allen shows EagleNXT is already operating on that footing, with U.S.-made, procurement-eligible systems moving from our floor to the field.”

The Fort Irwin delivery builds on broader U.S. Army adoption of the eBee VISION across training centers and operational units in the United States and Europe.

For more information about the full suite of EagleNXT UAS and sensor solutions, visit eaglenxt.com or contact the EagleNXT Media Relations team.

About EagleNXT

EagleNXT is a leading developer of high-performance drones, advanced sensors, and intelligent software solutions that deliver critical aerial intelligence to customers around the world. With more than one million flights conducted globally, EagleNXT’s platforms are trusted across defense, public safety, agriculture, infrastructure, and environmental monitoring applications. The Company’s drone systems have achieved multiple industry firsts, including FAA approvals for Operations Over People (OOP) and Beyond Visual Line of Sight (BVLOS), as well as EASA C2 certification in Europe and inclusion on the U.S. Department of Defense’s Blue UAS list. EagleNXT’s sensors are integrated on more than 150 different drone models and are used in over 100 research publications worldwide, reinforcing its leadership in precision agriculture, surveying, and environmental sustainability initiatives.

Forward-Looking Statements

Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “suggest,” “target,” “aim,” “should,” “will,” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on AgEagle’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict, including risks related to the timing and fulfilment of current and future purchase orders relating to AgEagle’s products, the success of new programs and software updates, the ability to implement a new strategic plan and the success of a new strategic plan. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of AgEagle in general, see the risk disclosures in the most recently filed Annual Report on Form 10-K and in subsequent reports on Forms 10-Q and 8-K and other filings made with the SEC by AgEagle. All such forward-looking statements speak only as of the date they are made, and AgEagle undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise.

Media Contact
Andy Woodward
+1 (469) 451-2344
Andy.woodward@EagleNXT.com

LinkedIn Facebook X YouTube

Investor Relations
Email: UAVS@EagleNXT.com

— First targeted therapy approved in Canada for patients four years and older living with acquired hypothalamic obesity (HO) —

BOSTON, Sept. 22, 2026 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that Health Canada has approved IMCIVREE^® (setmelanotide) for the additional indication of weight management in adult and pediatric patients 4 years of age and older with acquired hypothalamic obesity (HO). IMCIVREE was first approved by Health Canada in 2023 for weight management in adult and pediatric patients 6 years of age and older with obesity due to Bardet-Biedl syndrome (BBS), or genetically confirmed biallelic pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency due to variants interpreted as pathogenic, likely pathogenic, or of uncertain significance. Please consult the IMCIVREE product monograph available at www.rhythmtx.ca.

“Acquired hypothalamic obesity is a rare, complex MC4R pathway disease that develops following injury to the hypothalamus, resulting in accelerated and sustained weight gain, hyperphagia and significant impacts on quality of life,” said Jennifer Lee, Executive Vice President, Head of North America for Rhythm. “The approval of this additional indication for IMCIVREE provides healthcare professionals with an important new treatment option for eligible patients in Canada. We are grateful to the Canadian patient and healthcare community and look forward to working to make IMCIVREE available to patients living with acquired hypothalamic obesity.”

IMCIVREE, a melanocortin-4 receptor (MC4R) agonist, is the first targeted therapy approved in Canada to treat acquired HO. The Health Canada approval is based on the positive pivotal Phase 3 TRANSCEND trial of setmelanotide in 142 patients with acquired HO. The global study met its primary endpoint, demonstrating a statistically significant 18.8% placebo-adjusted reduction in body mass index (BMI). Results from the Phase 3 TRANSCEND trial were recently published in The New England Journal of Medicine.

“Patients living with acquired hypothalamic obesity face significant medical and quality-of-life challenges, and treatment options have been extremely limited,” said Jill Hamilton, M.D., Paediatric Endocrinologist at The Hospital for Sick Children. “This approval provides a treatment option that addresses the underlying MC4R pathway dysfunction associated with acquired hypothalamic obesity.”

Following this approval, Rhythm will continue with supporting access to IMCIVREE for patients with acquired HO across Canada.

Disclosure footnote: Dr. Jill Hamilton has received institutional support for industry sponsored studies, including setmelanotide trials from Rhythm Pharmaceuticals.

About Acquired Hypothalamic Obesity

Acquired HO is a rare disease characterized by accelerated and sustained weight gain caused by an injury to the hypothalamus. Hypothalamic injury may lead to decreased alpha-melanocyte-stimulating hormone (α-MSH) production and impairment of MC4R pathway signaling. The MC4R pathway is responsible for regulating energy balance and body weight. Acquired HO most frequently follows the growth or treatment of craniopharyngioma, astrocytoma, or other hypothalamic-pituitary tumors. Additional causes of injury may include traumatic brain injury, stroke, infection, or inflammation. Due to impairment of the MC4R pathway, patients experience accelerated and sustained weight gain, often accompanied by hyperphagia and/or decreased energy expenditure. Acquired hypothalamic obesity can occur as early as six months following hypothalamic injury. Acquired HO is a rare disease with limited epidemiologic data specific to Canada.

About Rhythm Pharmaceuticals
Rhythm is a commercial-stage biopharmaceutical company committed to transforming the lives of patients and their families living with rare neuroendocrine diseases. Rhythm’s lead asset, IMCIVREE^® (setmelanotide), an MC4R agonist designed to treat hyperphagia and severe obesity, is approved by the U.S. Food and Drug Administration (FDA) to reduce excess body weight and maintain weight reduction long term in adult and pediatric patients aged 4 years and older with acquired hypothalamic obesity, adult and pediatric patients 2 years of age and older with syndromic or monogenic obesity due to Bardet-Biedl syndrome (BBS) or genetically confirmed pro-opiomelanocortin (POMC), including proprotein convertase subtilisin/kexin type 1 (PCSK1), deficiency or leptin receptor (LEPR) deficiency. Both the European Commission (EC) and the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) have authorized setmelanotide for the treatment of obesity and control of hunger in patients 4 years of age and above with acquired hypothalamic obesity due to hypothalamic injury or impairment; and for the treatment of obesity and the control of hunger associated with genetically confirmed BBS or genetically confirmed loss-of-function biallelic POMC, including PCSK1, deficiency or biallelic LEPR deficiency in adults and children 2 years of age and above. Additionally, Rhythm is advancing a broad clinical development program for setmelanotide in other rare diseases, as well as investigational MC4R agonists bivamelagon and RM-718, and a preclinical suite of small molecules for the treatment of congenital hyperinsulinism. Rhythm’s headquarters is in Boston, MA.

Reporting side effects
You can report any suspected side effects associated with the use of health products to Health Canada by:

• Visiting the Web page on Adverse Reaction Reporting (canada.ca/drug-device-reporting) for information on how to report online, by mail or by fax; or
• Calling toll-free at 1-866-234-2345.

NOTE: Contact your healthcare professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Please see the Product Monograph at https://rhythmtx.ca/wp-content/uploads/2023/05/IMCIVREE-Product-Monograph-EN.pdf for complete safety information.

Forward-looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding the safety, efficacy, potential benefits of, and clinical design or progress of any of our products or product candidates at any dosage or in any indication, including, setmelanotide, bivamelagon, and RM-718; the use of setmelanotide in patients with acquired HO and the success of our commercial launch; our expectations surrounding potential regulatory submissions, progress, or approvals and timing thereof for any of our product candidates; the commercial growth of IMCIVREE; the estimated market size and addressable population for our drug products, including setmelanotide for the treatment of acquired HO; and the timing of any of the foregoing. Statements using words such as “expect”, “anticipate”, “believe”, “may”, “will” and similar terms are also forward-looking statements. Such statements are subject to numerous risks and uncertainties, including, but not limited to, our ability to enroll patients in clinical trials, the design and outcome of clinical trials, the impact of competition, the ability to achieve or obtain necessary regulatory approvals, risks associated with data analysis and reporting, unfavorable pricing regulations, third-party reimbursement practices or healthcare reform initiatives, risks associated with the laws and regulations governing our international operations and the costs of any related compliance programs, our ability to successfully commercialize setmelanotide, our liquidity and expenses, our ability to retain our key employees and consultants, and to attract, retain and motivate qualified personnel, and general economic conditions, and the other important factors, including those discussed under the caption “Risk Factors” in Rhythm’s Quarterly Report on Form 10-Q for the three months ended June 30, 2026, and our other filings with the Securities and Exchange Commission. Except as required by law, we undertake no obligations to make any revisions to the forward-looking statements contained in this release or to update them to reflect events or circumstances occurring after the date of this release, whether as a result of new information, future developments or otherwise.

Corporate Contacts:
David Connolly
Head of Investor Relations and Corporate Communications
Rhythm Pharmaceuticals, Inc.
857-264-4280
dconnolly@rhythmtx.com 

Kate Walsh
Director, Corporate Communications
Rhythm Pharmaceuticals, Inc.
(857) 264-4280
kwalsh@rhythmtx.com 

NORWALK, Conn., Sept. 22, 2026 (GLOBE NEWSWIRE) — FactSet, a leading global intelligence and AI solutions provider to the financial markets, today announced the acquisition of BCC Group International GmbH (bccg), a financial software development firm specializing in cloud-native and hybrid market data distribution platforms. The acquisition marks a milestone in the expansion of FactSet’s Real-Time Solution Suite, strengthening its market data management capabilities. Combined with its premium Real-Time Consolidated Data Feeds, it helps firms meet the demands of a rapidly evolving capital markets landscape.

For decades, market data infrastructure operated on the same premise: build or buy a platform, plug in data feeds, and let it operate. Trading is now moving toward 24-hour operations, AI is rewriting rules for workflows, and regulators are raising the bar on cross-vendor governance. Today, firms are building expensive workarounds for systems never designed to be open, modular, or cloud-ready. The hidden costs are becoming impossible to ignore: innovation timelines stretch, talent is redirected to maintenance, and compliance burdens continue to grow.

FactSet’s acquisition of bccg is a direct response to that challenge. Through the acquisition, FactSet brings bccg’s ONE Platform solution into its Real-Time Solution Suite, giving clients deployment flexibility without the overhead of monolithic systems. The acquisition strengthens FactSet’s real-time portfolio and represents a fundamental shift in how enterprise market data infrastructure can be designed and operated. Together, FactSet and bccg deliver:

• Open Ecosystem with Governed Access: The ability to combine exchange feeds, third-party content, and proprietary data in a single governed environment. Entitlements management, compliance reporting, and cost controls are now centralized rather than siloed.
• API-First Integration: Interoperable components designed to connect seamlessly to existing workflows. Built for the infrastructure clients have today and workflows they are building for tomorrow.
• Flexible Deployment: Choose cloud, on-premises, or hybrid models to match your existing infrastructure and evolving requirements. The ONE Platform modular architecture means clients can select and deploy the components they need.
• Managed Solution: Full-service operations with high availability, key performance indicators (KPIs), and market data management optimization.

FactSet and bccg have worked in collaboration together since 2021, solving real client problems and building technical alignment earned through delivery. The acquisition unites FactSet’s 25 years of real-time data investment with bccg’s modern distribution architecture. Clients gain a single, accountable partner for both content and infrastructure: one with a proven delivery record and the depth to support what comes next.

“Clients have told us they don’t just want another data vendor. They want a deeply invested open technology partner they already trust to manage their data. This acquisition is our response: FactSet’s content expertise, open architecture platform principles, and premier white-glove service, coupled with bccg’s modular, API driven, frictionless data management solution. Combined, our solutions are uniquely positioned to offer clients an alternative to the traditional monolithic offerings of yesterday.”– said Brian Herte, Global Head of Market Data & Trading at FactSet.

“We are excited to join forces with a truly global partner with the scale and ambition to drive a paradigm shift in financial market data. By combining bccg’s leading cloud-native market data distribution technology with FactSet’s comprehensive data and managed services, we can give financial institutions a genuinely source-neutral alternative to today’s lock-in. Openness and choice across the data ecosystem sit at the heart of that vision.” – said Mauricio Gonzalez Evans, CEO of BCC Group International GmbH.

This is not expected to have a material impact on FactSet’s financial results.

About FactSet

FactSet (NYSE:FDS | NASDAQ:FDS) supercharges financial intelligence, offering enterprise data and information solutions that help our clients maximize their potential. Our digital platform seamlessly integrates proprietary data, third-party sources, and flexible technology to deliver tailored solutions across the buy side, sell side, wealth, and corporate sectors. With over 47 years of expertise, we leverage advanced data connectivity, AI, and next-generation tools to streamline workflows and enable smarter decision-making. As an S&P 500 company serving more than 9,100 global clients and over 247,000 individual users, we are dedicated to innovation and long-term client success. Learn more at www.factset.com and follow us on X and LinkedIn.

About BCC Group International

BCC Group (bccgi.com) is a Germany-based financial technology provider specializing in cloud infrastructure and management solutions for real-time, historical, reference, and all other types of market data.

Founded over 20 years ago, the company delivers vendor-neutral platforms—such as its flagship ONE Platform—that enable banks, trading firms, and financial institutions to ingest, entitle, and distribute financial market data across hybrid, private, and public cloud environments (including AWS, Azure, and Google Cloud). By focusing on open integration, usage-based licensing controls, and cloud data governance, BCC Group helps financial organizations streamline data delivery, reduce data provider lock-in, and control market data infrastructure costs.

FactSet Investor Relations:
Kevin Toomey
+1.212.209.5259
Kevin.toomey@factset.com

FactSet Media Relations:
Alexandra Shevchenko
Oleksandra.shevchenko@factset.com

NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) — XFLH Capital Corporation, a publicly traded special purpose acquisition company (the “Company”), today announced the signing of a non-binding letter-of-intent (“Letter of Intent”) for a business combination with Renogen Biolab Inc., a Canadian corporation and a health service provider that offers and provides several core molecular capabilities including DNA services, vector engineering, and protein expression.

Pursuant to the Letter of Intent, the parties have agreed to use their reasonable best efforts to act in good faith to negotiate the definitive agreements embodying the Proposed Business Combination as soon as possible (“Definitive Agreements”), with the intent that the execution of such Definitive Agreements as soon as practicable hereafter. Both parties would also proceed with providing the other party and its representatives with reasonable access to information for the purpose of conducting a due diligence inquiry.

XFLH Capital Corporation

XFLH Capital Corporation is a blank check company formed under the laws of the Cayman Islands for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Forward Looking Statements

This press release includes forward-looking statements that involve risks and uncertainties. Forward looking statements are statements that are not historical facts. Such forward-looking statements, including those with respect to the Company’s search for an initial business combination, are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements, including those set forth in the Risk Factors section of the Company’s registration statement and final prospectus for the Company’s initial public offering filed with the SEC. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based, except as required by law.

For further information, please contact:

Yanzhe Yang | Chief Executive Officer
Phone: (551) 358-2652
Email: yanzheyang@xflh.online

Company Strengthens Engineering Leadership as SAF Production and Testing Program Moves Forward; Planned ASTM Testing and Qualification Activities Intended to Support Future Airline, Aircraft, Engine and U.S. Military Customers

SOUTHLAKE, Texas, Sept. 22, 2026 (GLOBE NEWSWIRE) — American EcoFuels Inc. (OTC: AEFI) (“American EcoFuels” or the “Company”), a developer of advanced synthetic fuel technologies, today announced the appointment of Jeff Saxinger as Chief Technology Officer (CTO), strengthening the Company’s technical and engineering leadership as it advances the development, construction and testing of its proprietary Gas-to-Liquids (“GTL”) and Coal-to-Liquids (“CTL”) technologies and prepares to produce aviation fuel for testing and qualification.

Saxinger, a Professional Engineer (P.Eng.), brings more than 32 years of engineering and project-management experience, including 13 years in shop fabrication engineering. His background encompasses mechanical, process, electrical and instrumentation disciplines, as well as extensive experience with compressors, turboexpanders, pumps and modular process systems. He has led multidisciplinary teams through preliminary engineering, front-end engineering and design (“FEED”), detailed engineering, procurement, construction and commissioning.

His experience also includes the engineering of gas-processing plants involving separation, compression, amine sweetening, refrigeration, glycol dehydration, CO₂ removal, liquids fractionation, steam and hot-oil systems, and waste-heat recovery.

“Jeff is a great addition to our team and to American EcoFuels at an important point in the Company’s development, as our engineering effort for producing SAF for testing is starting now,” said Brent Nelson, Executive Chairman of American EcoFuels. “Jeff brings decades of practical engineering, fabrication, project-management and gas-processing experience. We believe that experience will be extremely valuable as we move our technology from engineering and development into physical systems capable of producing fuels for testing.”

Nelson continued, “Our objective is not simply to demonstrate that we can produce a synthetic aviation fuel. We intend to undertake the applicable ASTM testing and qualification pathway for our aviation fuels, with the goal of developing fuels capable of being accepted for their intended applications by commercial airlines, aircraft and engine manufacturers, and appropriate branches and programs of the U.S. military. As that technical and qualification work advances, one of our commercial objectives is to begin developing and pursuing potential offtake agreements with these categories of customers.”

Extensive Process and Project Engineering Experience

Saxinger’s experience is particularly relevant to American EcoFuels’ planned development program. His recent work includes serving as project manager on a multidisciplinary team designing and building a major greenfield sour-gas processing plant with sulfur recovery and serving as Project Engineering Manager for the refurbishment of a steam methane reformer hydrogen-generation plant used to supply a diesel desulfurization process.

Earlier in his career, Saxinger managed and engineered major gas-processing, compression, fractionation, pumping and related infrastructure projects. His experience includes a 33,000-barrel-per-day C2+ fractionation train FEED project, gas compressor stations, liquids-handling facilities and sour-gas processing plants.

Saxinger also has extensive fabrication-shop and field experience involving high-pressure compressor systems, CO₂ injection systems, process equipment, piping, pumps, valves and instrumentation. His technical background includes work with API and ASME engineering standards relevant to petroleum, petrochemical and natural-gas processing equipment.

Saxinger earned a Bachelor of Science in Civil Engineering from the University of Saskatchewan and has completed additional university-level coursework in natural-gas processing as well as specialized training involving underground gas storage, acid-gas compression and injection, reciprocating compressors and ASME piping codes. He is a member of the Association of Professional Engineers and Geoscientists of Alberta and the Association of Professional Engineers and Geoscientists of Saskatchewan.

Leadership and Engineering Update

As American EcoFuels accelerates its proprietary GTL and CTL development and testing program, Travis Yakimishyn is assuming the role of Senior Electrical Engineer, allowing him to take an even more hands-on role in the Company’s engineering activities.

In this position, Yakimishyn will focus his experience directly on the design, development, testing and advancement of electrical and technical solutions supporting the American EcoFuels GTL and CTL platforms. The Company believes this increased engineering focus will further strengthen the technical team as American EcoFuels progresses from its current experimental program toward increasingly advanced systems.

With Saxinger serving as Chief Technology Officer and Yakimishyn assuming a more focused and hands-on engineering role, the Company intends to build an integrated engineering organization capable of supporting process engineering, system integration, fabrication, commissioning, fuel production, testing and eventual commercial-scale deployment.

From Engineering to Fuel Qualification and Commercial Offtake

American EcoFuels is developing proprietary GTL and CTL processes designed to convert carbon-containing feedstocks into synthesis gas and subsequently into synthetic hydrocarbons through catalytic conversion and downstream upgrading.

The Company’s current development strategy is designed to progress from engineering and experimental work toward the production of sufficient quantities of aviation fuel for laboratory evaluation and subsequent qualification activities.

American EcoFuels intends to pursue the applicable ASTM International qualification and specification pathway required for its particular synthetic aviation-fuel pathway. The Company expects this process to involve extensive analytical testing and evaluation of fuel properties and performance. Any ultimate use of the Company’s fuels by commercial or military customers would remain subject to the applicable ASTM specifications, regulatory requirements, customer approvals and, where relevant, military fuel specifications and qualification procedures.

The Company believes successful progression through this process could provide the technical foundation for discussions with:

• Commercial airlines and aviation-fuel purchasers;
• Aircraft manufacturers;
• Commercial and military aircraft-engine manufacturers;
• Fuel distributors and suppliers; and
• U.S. Department of Defense and individual military-service procurement programs.

In parallel with its engineering and fuel-testing program, American EcoFuels intends to pursue discussions regarding potential long-term fuel offtake agreements. Such agreements, if successfully negotiated, could provide future commercial facilities with contracted demand and assist the Company in planning production capacity and project financing.

About American EcoFuels Inc.

American EcoFuels Inc. (OTC: AEFI) is developing advanced synthetic fuel technologies intended to convert natural gas and coal-derived feedstocks into high-performance liquid hydrocarbons, including Sustainable Aviation Fuel, synthetic paraffinic kerosene, modified clean diesel and related engineered fuels.

Through its GTL and CTL technology platforms, proprietary catalysts and expanding intellectual property portfolio, American EcoFuels is working toward fuels designed to provide the high energy density required by aviation, transportation, defense and industrial applications while utilizing existing engines and fuel infrastructure where applicable and following required testing and certification.

The Company’s development strategy encompasses technology engineering, intellectual property development, test-plant operation, fuel testing and certification, strategic partnerships, potential commercial production projects and prospective technology licensing.

American EcoFuels – From Discovering Energy to Engineering It.

Forward-Looking Statements

This news release contains statements regarding future events, expectations, plans, objectives and potential outcomes that are forward-looking in nature and are subject to significant risks and uncertainties. These statements include, among others, statements concerning the anticipated contributions of the Company’s Chief Technology Officer and engineering personnel; the development, testing, qualification, financing and commercialization of the Company’s technologies; production of aviation fuel for testing; ASTM qualification and specification activities; regulatory, military or customer acceptance; expansion of the Company’s intellectual property portfolio; potential strategic partnerships, offtake arrangements, production facilities and licensing opportunities; and the Company’s ability to execute its business plan.

Forward-looking statements are based on management’s current expectations, estimates, assumptions and projections and involve risks and uncertainties that could cause actual results, developments or events to differ materially from those anticipated. There can be no assurance that the Company’s technologies will achieve expected performance, that its fuels will successfully complete applicable testing or qualification processes or obtain required certifications, that ASTM specifications or other regulatory or customer requirements will be satisfied, that airlines, aircraft or engine manufacturers, the U.S. Department of Defense or any branch of the U.S. military will approve, purchase or use the Company’s fuels, or that the Company will successfully finance, scale or commercialize its technologies. Additional risks include engineering and scale-up risks, intellectual property challenges, financing requirements, regulatory developments, feedstock availability and pricing, competition, market acceptance, environmental requirements and general economic conditions.

Readers should not place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date they are made, and American EcoFuels undertakes no obligation to publicly update or revise such statements except as required by applicable law.

Company Contact

American EcoFuels Inc.
OTC: AEFI
Phone: 877.233.4485 ext. 730
Email: info@americanecofuelsinc.com
Website: www.americanecofuelsinc.com

DUBAI, United Arab Emirates, Sept. 22, 2026 (GLOBE NEWSWIRE) — Swvl Holdings Corp (“Swvl” or the “Company”) (Nasdaq: SWVL), a leading provider of technology-enabled mass mobility solutions, today announced the launch of a 24/7 shuttle service connecting seven hotels in Madinah, Kingdom of Saudi Arabia (“KSA”), to Al-Masjid an-Nabawi and the city’s most visited sites. This launch marks Swvl’s entry into Madinah, with the first focus on hospitality and pilgrimage transport segment, deepening the Company’s presence in the KSA, one of its most strategic growth markets.

Pursuant to the agreement between the Company and its Client, Swvl will operate a dedicated shuttle network connecting the seven participating hotels in Madinah to Al-Masjid an-Nabawi and the city’s most visited sites around the clock, leveraging Swvl’s platform to enable fixed route planning, real-time dispatching, and operational optimization. This deployment is designed to give hotel guests continuous, reliable access to these sites regardless of time of day.

The launch reinforces Swvl’s strategy of expanding into high-frequency, high-demand mobility verticals within the KSA. According to the Madinah Chamber of Commerce, Madinah welcomed more than 10 million visitors in 2025, drawn by the city’s religious, historical, and cultural landmarks. Religious tourism has emerged as a growing focus area for the Company in the KSA, driven by a steady, year-round demand from hotel operators for a scalable, always-on transport across the city.

This launch follows a series of recent contract wins in the KSA, including Swvl’s expansion into the banking sector with Bank Albilad, as reported in July 2026, underscoring sustained demand for technology-enabled transportation across both enterprise and consumer-facing sectors in the KSA.

With this launch, Swvl aims to continue advancing its regional expansion strategy, deepening its presence in the KSA and reinforcing its position as a provider of technology-enabled mobility solutions across high-growth markets in the KSA.

“Madinah is one of the highest-demand mobility markets in the KSA, and we believe that this launch reflects the breadth of demand for technology-enabled transportation across essential, non-corporate sectors,” said Mostafa Kandil, Chief Executive Officer of Swvl. “We believe that operating a 24/7 shuttle network for hotel guests underscores our ability to deliver reliable, technology-led transportation at scale, and we expect to build on this presence as we grow further in the KSA.”

“We believe that this launch further demonstrates the versatility of Swvl’s platform beyond traditional enterprise and government verticals,” added Ahmed Misbah, Chief Financial Officer of Swvl. “We believe that this milestone follows a deliberate strategy of expanding deeper into our current operating markets, in parallel to the new markets we are entering, and that the KSA remains to be a very large and promising market for our expansion ambitions.”

About Swvl

Swvl Holdings Corp (NASDAQ: SWVL) is a leading provider of technology-driven mobility solutions for enterprises and governments. Its platform leverages real-time data, adaptive networks, and advanced technology to deliver safer, more reliable, and sustainable transportation solutions. Swvl serves corporate clients, government institutions, schools, and healthcare providers across Egypt, the Kingdom of Saudi Arabia, the UAE, Kuwait, Qatar, the United Kingdom, and the United States. For more information, visit www.swvl.com.

Forward-Looking Statements

This press release contains “forward-looking statements” relating to future events. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding Swvl’s ability to deepen its presence in the KSA; the anticipated benefits and operation of the shuttle service in Madinah; the benefits of its products and services; Swvl’s ability to perform its obligations under the agreement; its expansion strategy and presence in the KSA; its belief that the launch reflects sustained demand for technology-enabled transportation across enterprise and consumer-facing sectors; and its focus on securing longer-duration contracts that generate predictable, recurring revenue.

These statements are based on the current expectations of Swvl’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions; many are beyond the control of Swvl. These statements are subject to a number of risks and uncertainties regarding Swvl’s business, and actual results may differ materially. More detailed information about the risks and uncertainties affecting the Company is contained under the heading “Risk Factors” in the Company’s annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission (the “SEC”), which is available on the SEC’s website, www.sec.gov, and in subsequent SEC filings.

Contact

Investor Relations: ir@swvl.com

Ahmed Misbah, Chief Financial Officer of Swvl: ahmed.misbah@swvl.com

Nes-Ziona, Israel, Sept. 22, 2026 (GLOBE NEWSWIRE) — Enlivex Ltd. (Nasdaq: ENLV) (“Enlivex” or the “Company”), a quality longevity company powered by a prediction markets treasury, today announced the termination of a securities purchase agreement entered into with the Rain Foundation, pursuant to which the Company had agreed, subject to shareholder approval, to sell and issue to the Rain Foundation in a private placement an aggregate of 66,666,667 of the Company’s ordinary shares, which the investor had elected to purchase using RAIN tokens.

The Company terminated the securities purchase agreement in accordance with the Company’s termination rights thereunder; therefore, the Company will not consummate the private placement contemplated thereby nor seek shareholder approval in respect thereof.

About Enlivex (Nasdaq: ENLV)

Enlivex is a quality longevity company powered by a prediction markets treasury. The Company is advancing Allocetra™, an advanced clinical-stage immunotherapy targeting inflammatory conditions associated with aging, with a primary focus on age-related osteoarthritis. In addition to its clinical programs, Enlivex operates a prediction markets treasury strategy built around the Rain protocol, the leading decentralized prediction markets infrastructure on Arbitrum. This dual strategy combines the development of quality longevity therapeutics with exposure to the emerging prediction markets ecosystem.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements may be identified by words such as “expects,” “plans,” “projects,” “will,” “may,” “anticipates,” “believes,” “should,” “would,” “could,” “intends,” “estimates,” “suggests,” “target,” “has the potential to,” “goal,” and other words of similar meaning, including statements relating to the anticipated benefits of the Company’s digital asset treasury strategy; the assets to be held by the Company; the expected future market, price, trading activity, and liquidity of the RAIN token; the impact of expanded exchange listings and increased token liquidity on market participation and accessibility; the potential effects of digital asset liquidity on the liquidity of the Company’s ordinary shares; macroeconomic, political, and regulatory conditions surrounding digital assets; the Company’s plans for value creation and strategic positioning; market size and growth opportunities; regulatory conditions; competitive position; technological and market trends; future financial condition and performance; expected clinical trial results; market opportunities for the results of current clinical studies and preclinical experiments; and the effectiveness of, and market opportunities for, ALLOCETRA™ programs.

Each forward-looking statement contained in this press release is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement. Applicable risks and uncertainties include, among others, the risk of failure to realize the anticipated benefits of the Company’s digital asset treasury strategy; changes in business, market, financial, political, and regulatory conditions; risks relating to the Company’s operations and business, including the highly volatile nature of the price, trading volume, and liquidity of RAIN and other cryptocurrencies; risks associated with digital asset exchange listings, trading venues, and market infrastructure; the risk that the price and liquidity of the Company’s ordinary shares may be correlated with the price or liquidity of the digital assets it holds; risks related to increased competition in the industries in which the Company operates; risks relating to significant legal, commercial, regulatory, and technical uncertainty regarding digital assets generally; risks relating to the treatment of crypto assets for U.S. and foreign tax purposes; and those risks and uncertainties identified in the Company’s filings with the Securities and Exchange Commission. The forward-looking statements in this press release speak only as of the date of this document, and the Company undertakes no obligation to update or revise any of these statements, except as required by applicable law.

ENLIVEX CONTACT

Shachar Shlosberger, CFO Enlivex Ltd. shachar@enlivex.com

TrainAlta’s flagship Warrior Training Program is expected to expand by approximately 29% by location count, adding Tennessee and the Chicago market

Highlights

• Pre-sale is open at 27 UFC GYM locations across seven states for the next cycle of TrainAlta’s flagship Warrior Training Program
• November is anticipated to be the largest launch in the UFC GYM partnership’s history
• Based on the current location list, the next cycle would be approximately 29% larger than the current cycle by location count
• TrainAlta expands into Tennessee and Chicago, while adding further locations in California
• The current program cycle remains underway at 21 UFC GYM locations across five states
• Consumers can learn more about TrainAlta and find available programs at trainalta.com

New York, NY, Sept. 22, 2026 (GLOBE NEWSWIRE) — Mixed Martial Arts Group Limited (NYSE American: MMA) (“MMA” or the “Company”), doing business as MMA.INC, today announced the continued expansion of TrainAlta within UFC GYM, with pre-sale now open at 27 UFC GYM locations for the next cycle of TrainAlta’s flagship Warrior Training Program. The cycle is scheduled to commence November 9, 2026 and, based on the current location list, is expected to be the largest launch in the partnership’s history.

TrainAlta Expands Within UFC GYM

TrainAlta is MMA.INC’s consumer-facing martial arts training platform and the home of one of the most established global pathways into MMA for beginners. Its flagship Warrior Training Program has introduced thousands of participants to the sport through programs delivered across North America, Europe, Australia and New Zealand, including at iconic gyms such as SBG Ireland, City Kickboxing, DC Wrestling Academy and Xtreme Couture. That global community is also showcased on Instagram at @TrainAlta where participant stories, program features and widely shared training and Fight Night moments bring the energy and personal impact of the TrainAlta experience to life.

The program’s proven 20 week, 100 lesson syllabus, converts interest in MMA into structured participation through progressive, coach led training across multiple martial arts disciplines. It is designed for beginners as well as experienced participants, with eligible graduates offered the opportunity to compete in a fully sanctioned amateur MMA bout in front of a live crowd at an “Alta Finale Fight Night”.

The UFC GYM rollout extends this established model across a major international gym network, while trainalta.com provides a central destination where prospective participants can learn about the program, find participating locations and secure their place.

Largest TrainAlta Program Cycle Now in Pre-Sale

The planned November footprint spans over 27 UFC GYM locations across seven states. It adds Hendersonville, Tennessee, together with three Chicago area locations in Morgan Park, Wrigleyville and Naperville.

In California, the pre-sale footprint expands with the addition of Anaheim and Point Loma. The pre-sale location list remains subject to change before the launch date.

Current Cycle Underway Across 21 Locations

The current TrainAlta Warrior Training Program cycle is underway at 21 UFC GYM locations across New York, Florida, Hawaii, Washington and California, making it the largest cycle launched to date. Based on the current pre-sale footprint, the planned November cycle would increase the number of locations in a single launch cycle by approximately 29%.

Finale Fight Nights Support Grassroots Combat Sports

Eligible participants who complete the current cycle are expected to have the opportunity to compete at a finale Fight Night, with an event planned in each participating state.

The events are planned to be staged by TrainAlta and UFC GYM, either directly or with local promotion partners. The format gives participants a defined training goal while directing program activity and investment toward grassroots promotions and the coaches, officials and local combat sports communities that support them.

Nick Langton, Founder and Chief Executive Officer of MMA.INC, said:
Our mission is to turn hundreds of millions of MMA fans around the world into active participants. Watching the sport can inspire people, but stepping onto the mats can change a life. It demands discipline, builds confidence and connects people to a community in a way few other experiences can.

“The Warrior Training Program is the flagship expression of that mission. It gives people, many of whom are entering a combat sports gym for the first time, a globally proven 20 week, 100 lesson journey and the opportunity to test themselves at a finale Fight Night. Our current 21 location UFC GYM cycle is the largest we have launched to date, and pre-sale is now open at 27 locations for November.

“Every additional location creates another entry point into MMA. As the physical footprint grows, trainalta.com provides the front door through which fans can understand the program, find a participating gym and make the commitment to begin. The finale Fight Nights then give eligible participants a defining goal while directing investment toward the local promoters, coaches, officials and emerging talent who sustain the sport at its grassroots.”

About TrainAlta

TrainAlta is MMA.INC’s consumer facing martial arts training platform, built to turn global interest in combat sports into structured participation. Since 2018, its flagship Warrior Training Program has introduced many thousands of people to MMA through programs delivered across North America, Europe, Australia and New Zealand, including through iconic gyms such as SBG Ireland and City Kickboxing.

The Warrior Training Program is a proven 20 week, 100 lesson syllabus that takes participants from foundational skills and conditioning through technical development and fight preparation. It is designed for beginners as well as experienced martial artists, with eligible graduates having the opportunity to compete in an amateur MMA finale bout, subject to applicable fitness, skill, suitability and regulatory requirements.

TrainAlta’s broader offering includes the In Gym Training Pass, Online Academy and Alta for Gyms, creating additional pathways for participants and partner gyms to engage beyond the flagship program.

For more information or to find an available program, visit trainalta.com

About Mixed Martial Arts Group Limited

Mixed Martial Arts Group Limited (NYSE American: MMA), doing business as MMA.INC, is building the participation and technology platform for the global martial arts and combat sports industry, connecting practitioners, gyms, coaches, content, commerce and payments.

As of July 2026, MMA.INC’s platform assets included 5 million+ social media followers, 680,000 user profiles, 107,694 registered student profiles, 27,651 monthly active users and 15,326 published gym profiles, including 996 verified and 389 paying academies. The platform also recorded approximately 80,000 monthly check-ins and an annualized payments run rate of approximately US$21 million based on May 2026 processing volumes.

• A Connected Participation Platform: MMA.INC brings together gym software, payments, training, community, content and commerce through assets including BJJLink, TrainAlta, Hype and MixedMartialArts.com.
• A Growing Participation Network: Over the prior 18 months, registered student profiles increased approximately 101%, monthly active users approximately 89% and paying academies approximately 260%.
• Built to Aggregate the Sector: MMA.INC’s strategy is to connect the fragmented martial arts participation economy through a unified digital identity and ecosystem designed to deepen engagement and expand monetization across software, payments, programs, memberships, partnerships and commerce.

For more information, visit www.mma.inc

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Sections 27A of the Securities Act of 1933 and 21E of the Securities Exchange Act of 1934. Words such as “believe,” “may,” “estimate,” “anticipate,” “intend,” “plan,” “could,” “target,” “potential,” “will,” “expect” and similar expressions are intended to identify forward-looking statements. These statements include, without limitation, statements regarding the continued expansion of TrainAlta within UFC GYM; the scheduled November 9, 2026 commencement of the next Warrior Training Program cycle; the number and location of UFC GYM sites expected to participate; the expected size of the launch; geographic expansion; participant enrollment, completion and eligibility; the timing, number and format of finale Fight Night events; the ability of TrainAlta.com to support program awareness and enrollment; the Company’s relationships with UFC GYM and local promotion partners; and MMA.INC’s strategy, plans and objectives, growth and monetization of its platform, increased penetration of existing users, students, gyms and other platform assets, development and adoption of products and programs, partnerships, geographic expansion, acquisitions, strategic investments, payment volumes, and future revenue, margins, operating performance and financial condition. Forward-looking statements are based on management’s current expectations, assumptions and estimates and are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. These include, among others, changes to participating locations or launch timing; pre-sale conversion, cancellations and participant demand; the ability of MMA.INC, UFC GYM and promotion partners to deliver programs and events as planned; the Company’s ability to manage growth; the adoption and commercialization of its products and services; its dependence on gyms, academies, members, partners and key relationships; competition; execution and integration risks associated with acquisitions; regulatory developments; macroeconomic conditions; access to capital; and the risks described in the Company’s Annual Report on Form 20-F and subsequent reports on Form 6-K filed with or furnished to the U.S. Securities and Exchange Commission. There can be no assurance that the next Warrior Training Program cycle will commence on the anticipated date, include all currently listed locations, achieve expected participation levels or be the largest launch in the partnership’s history. There can also be no assurance that TrainAlta.com will generate increased awareness or enrollment or that the planned finale Fight Night events will occur at the anticipated times, in the anticipated locations or in the manner described. There can be no assurance that any forward-looking outcome will be achieved. MMA.INC’s products and business lines are at varying stages of development, commercialization and adoption, and certain products, services or features may be modified, delayed or discontinued. Forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update or revise any forward-looking statement except as required by applicable law.

Media Contacts

Mixed Martial Arts Group Limited
E: andrew@mma.inc